Showing results (121-130 of 237) with videos related to

Sort By:
Pageof 24
International Journal of Cardiology|July 9, 2016
Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failureTakaaki Furihata, Shintaro Kinugawa, Arata Fukushima, et al.
Cancers|December 11, 2025
Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal CancerHiromichi Maeda, Koji Oba, Kosuke Kashiwabara, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2021
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study)Keiichiro Ishibashi, Toru Aoyama, Masahito Kotaka, et al.
Radiology|April 30, 2015
Transcatheter Arterial Embolization with Ethanol Injection in Symptomatic Patients with Enlarged Polycystic KidneysYusuke Sakuhara, Saori Nishio, Ken Morita, et al.
Medical Molecular Morphology|September 6, 2013
Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in ratsIan Fukudome, Michiya Kobayashi, Ken Dabanaka, et al.
Oncology|November 20, 2017
Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study GroupTomoiku Takaku, Noriyoshi Iriyama, Toru Mitsumori, et al.
Cerebellum (London, England)|June 22, 2015
Comparison of Different Symptom Assessment Scales for Multiple System AtrophyMasaaki Matsushima, Ichiro Yabe, Koji Oba, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 5, 2014
Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasmsHiromi Fujita, Yutaka Hatanaka, Yoichi Sutoh, et al.
Frontiers in Oncology|October 9, 2014
The potential diagnostic role of the number of ultrasonographic characteristics for patients with thyroid nodules evaluated as bethesda I-vTomohiro Sakashita, Akihiro Homma, Hiromitsu Hatakeyama, et al.
BMC Cancer|October 16, 2015
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET studyHitoshi Soda, Hiromichi Maeda, Junichi Hasegawa, et al.
Pageof 24